Literature DB >> 28591128

After Glybera's withdrawal, what's next for gene therapy?

Melanie Senior.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28591128     DOI： 10.1038/nbt0617-491

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Gene therapy 'cure' for blindness wanes.

Authors:  Anna Azvolinsky
Journal:  Nat Biotechnol       Date:  2015-07       Impact factor: 54.908

2.  Early clinical data raise the bar for hemophilia gene therapies.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2016-10-11       Impact factor: 54.908

3.  First gene therapy nears landmark European market authorization.

Authors:  Nuala Moran
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908
  3 in total
  19 in total

1.  Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Authors:  Ming Jing Wu; Anna Wolska; Benjamin S Roberts; Ellis M Pearson; Aspen R Gutgsell; Alan T Remaley; Saskia B Neher
Journal:  J Lipid Res       Date:  2018-10-14       Impact factor: 5.922

Review 2.  Biopolymers augment viral vectors based gene delivery.

Authors:  Balaji Balakrishnan; Ernest David
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

Review 3.  The Landscape of Early Clinical Gene Therapies outside of Oncology.

Authors:  Laure Rittié; Takis Athanasopoulos; Miguel Calero-Garcia; Marie L Davies; David J Dow; Steven J Howe; Alastair Morrison; Ida Ricciardelli; Aurore Saudemont; Laurent Jespers; Timothy M Clay
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

4.  Protection is not always a good thing: The immune system's impact on gene therapy.

Authors:  Martiela Vaz de Freitas; Lariane Frâncio; Laura Haleva; Ursula da Silveira Matte
Journal:  Genet Mol Biol       Date:  2022-07-15       Impact factor: 2.087

Review 5.  Gene Therapy Strategies to Restore ER Proteostasis in Disease.

Authors:  Vicente Valenzuela; Kasey L Jackson; Sergio P Sardi; Claudio Hetz
Journal:  Mol Ther       Date:  2018-04-07       Impact factor: 11.454

6.  Viral Vector Technologies and Strategies: Improving on Nature.

Authors:  Roxanne H Croze; Melissa Kotterman; Christian H Burns; Chris E Schmitt; Melissa Quezada; David Schaffer; David Kirn; Peter Francis
Journal:  Int Ophthalmol Clin       Date:  2021-07-01

Review 7.  Tuning up Transcription Factors for Therapy.

Authors:  Attila Becskei
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

Review 8.  In vivo gene delivery mediated by non-viral vectors for cancer therapy.

Authors:  Reza Mohammadinejad; Ali Dehshahri; Vijay Sagar Madamsetty; Masoumeh Zahmatkeshan; Shima Tavakol; Pooyan Makvandi; Danial Khorsandi; Abbas Pardakhty; Milad Ashrafizadeh; Elham Ghasemipour Afshar; Ali Zarrabi
Journal:  J Control Release       Date:  2020-07-04       Impact factor: 9.776

Review 9.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

Review 10.  Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.

Authors:  Allen Lin; Alejandro B Balazs
Journal:  Retrovirology       Date:  2018-10-01       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.